FY revenue beat guidance
06/09/21 -"Bastide’s FY revenue was better than projected and the guidance for the underlying operating margin has been reconfirmed. Due to the one-off tailwind effect in this H1, the group forecasts a more ..."
Pages
50
Language
English
Published on
06/09/21
You may also be interested by these reports :
12/09/25
DiaSorin appears to be making significant progress in the testing space. The launch of speciality tests, introduction of the Plex platform, and ...
05/09/25
Bastide reported FY24/25 revenue in line with guidance and our forecast. The more technical business activities remain the primary driver of organic ...
05/09/25
Since we last pushed Philips’ (Buy; Netherlands) investment case in January 2024, its share price performance has been glaringly ahead of the MedTech ...
04/09/25
bioMerieux’s H1 profitability surpassed expectations. Topline growth was driven by robust performance across both segments. However, weakness in ...